Compare
Fidelity Ethereum Fund vs Core Scientific, Inc./tx vs Hyperliquid Strategies Inc vs Sharplink, Inc.
| Latest fiscal year | Fidelity Ethereum Fund FETH | Core Scientific, Inc./tx CORZ | Hyperliquid Strategies Inc PURRRevenue covers only part of its income (partial revenue) | Sharplink, Inc. SBET |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2026-06-30 | 2025-12-31 |
| Revenue | n/a | $319.02M | n/a | $28.05M |
| Revenue growth (YoY) | n/a | -37.5% | n/a | +666.1% |
| Gross margin | n/a | 11.9% | n/a | n/a |
| Operating margin | n/a | -77.0% | n/a | n/m |
| Net margin | n/a | -90.5% | n/a | n/m |
| Net income | -$422.30M | -$288.62M | $305.54M | -$734.59M |
| EPS (Diluted) | n/a | -$0.88 | $3.21 | -$7.37 |
| Operating cash flow | -$1.04B | $278.25M | -$19.15M | -$17.54M |
| Free cash flow | n/a | -$450.75M | n/a | -$17.55M |
| Cash & equivalents | n/a | $311.38M | $137.92M | n/a |
| Total assets | $2.21B | $2.35B | $2.06B | $2.43B |
| Total liabilities | $2.67M | $3.31B | $187.14M | $12.75M |
| Shareholders' equity | $2.21B | -$962.74M | $1.87B | $2.42B |
| Return on year-end equity | -19.1% | n/a | 16.3% | -30.4% |
| Shares outstanding | 74.55M | 314.23M | 200.55M | 196.70M |
Revenue, most recent five fiscal years
| Fiscal year | Fidelity Ethereum Fund | Core Scientific, Inc./tx | Hyperliquid Strategies Inc | Sharplink, Inc. |
|---|---|---|---|---|
| Latest | n/a | $319.02M Ended 2025-12-31 | n/a | $28.05M Ended 2025-12-31 |
| 1 year earlier | n/a | $510.67M Ended 2024-12-31 | n/a | $3.66M Ended 2024-12-31 |
| 2 years earlier | n/a | $502.40M Ended 2023-12-31 | n/a | $4.95M Ended 2023-12-31 |
| 3 years earlier | n/a | $640.31M Ended 2022-12-31 | n/a | $3.49M Ended 2022-12-31 |
| 4 years earlier | n/a | $544.48M Ended 2021-12-31 | n/a | n/a |